[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR2422402A1 - COMPOSITION BASED ON 3-B-METHOXYETHYL AND 5-ISOPROPYL ESTER OF 1,4-DIHYDRO-2,6-DIMETHYL-4- (3'-NITROPHENYL) PYRIDINE, INTENDED FOR CEREBRAL THERAPEUTICS - Google Patents

COMPOSITION BASED ON 3-B-METHOXYETHYL AND 5-ISOPROPYL ESTER OF 1,4-DIHYDRO-2,6-DIMETHYL-4- (3'-NITROPHENYL) PYRIDINE, INTENDED FOR CEREBRAL THERAPEUTICS

Info

Publication number
FR2422402A1
FR2422402A1 FR7909029A FR7909029A FR2422402A1 FR 2422402 A1 FR2422402 A1 FR 2422402A1 FR 7909029 A FR7909029 A FR 7909029A FR 7909029 A FR7909029 A FR 7909029A FR 2422402 A1 FR2422402 A1 FR 2422402A1
Authority
FR
France
Prior art keywords
methoxyethyl
nitrophenyl
dihydro
pyridine
dimethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7909029A
Other languages
French (fr)
Other versions
FR2422402B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6036687&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR2422402(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer AG filed Critical Bayer AG
Publication of FR2422402A1 publication Critical patent/FR2422402A1/en
Application granted granted Critical
Publication of FR2422402B1 publication Critical patent/FR2422402B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention a trait au domaine de la chimie médicale. Elle concerne un médicament contenant l'ester de 3- beta -méthoxyéthyle et de 5-isopropyle de la 1,4-dihydro-2,6-diméthyl-4-(3'-nitrophényl)pyridine. Application à la thépeutique cérébrale.The invention relates to the field of medical chemistry. It relates to a medicament containing the 3-beta -methoxyethyl and 5-isopropyl ester of 1,4-dihydro-2,6-dimethyl-4- (3'-nitrophenyl) pyridine. Application to cerebral therapy.

FR7909029A 1978-04-11 1979-04-10 COMPOSITION BASED ON 3-B-METHOXYETHYL AND 5-ISOPROPYL ESTER OF 1,4-DIHYDRO-2,6-DIMETHYL-4- (3'-NITROPHENYL) PYRIDINE, INTENDED FOR CEREBRAL THERAPEUTICS Granted FR2422402A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2815578A DE2815578C2 (en) 1978-04-11 1978-04-11 New pharmaceutical use of nimodipine

Publications (2)

Publication Number Publication Date
FR2422402A1 true FR2422402A1 (en) 1979-11-09
FR2422402B1 FR2422402B1 (en) 1982-07-02

Family

ID=6036687

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7909029A Granted FR2422402A1 (en) 1978-04-11 1979-04-10 COMPOSITION BASED ON 3-B-METHOXYETHYL AND 5-ISOPROPYL ESTER OF 1,4-DIHYDRO-2,6-DIMETHYL-4- (3'-NITROPHENYL) PYRIDINE, INTENDED FOR CEREBRAL THERAPEUTICS

Country Status (27)

Country Link
US (1) US4406906A (en)
EP (1) EP0004650B1 (en)
JP (3) JPS54135776A (en)
AT (1) AT383271B (en)
AU (1) AU532623B2 (en)
BE (1) BE875457A (en)
CA (1) CA1140853A (en)
CH (3) CH640734A5 (en)
DE (2) DE2815578C2 (en)
DK (1) DK150479A (en)
ES (1) ES479474A1 (en)
FI (1) FI791162A (en)
FR (1) FR2422402A1 (en)
GB (1) GB2018134A (en)
GR (1) GR71463B (en)
HK (1) HK59188A (en)
IE (1) IE51651B1 (en)
IL (1) IL57030A (en)
IT (1) IT1062201B (en)
LU (2) LU88273I2 (en)
NL (2) NL7902778A (en)
NO (1) NO791009L (en)
NZ (1) NZ190133A (en)
PH (1) PH15574A (en)
SE (1) SE447248B (en)
SG (1) SG18688G (en)
ZA (1) ZA791728B (en)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3142853A1 (en) * 1981-10-29 1983-05-11 Bayer Ag, 5090 Leverkusen Solid pharmaceutical compositions containing nifedipine and process for their production
DE3270785D1 (en) * 1981-10-29 1986-05-28 Bayer Ag Process for preparing solid fast-releasing drug formulations of dihydropyridines
JPS58172312A (en) * 1982-04-02 1983-10-11 Toa Eiyou Kagaku Kogyo Kk Nifedipine of external use agent
JPS58177916A (en) * 1982-04-13 1983-10-18 Kowa Co External drug
DE3307422A1 (en) * 1983-03-03 1984-09-06 Bayer Ag, 5090 Leverkusen LIQUID PREPARATIONS OF DIHYDROPYRIDINES, A METHOD FOR THE PRODUCTION THEREOF AND THEIR USE IN THE FIGHT AGAINST DISEASES
US4690935A (en) * 1983-03-31 1987-09-01 Wayne State University Inhibition of tumor growth and metastasis with calcium channel blocker compounds
DE3316510A1 (en) * 1983-05-06 1984-11-08 Bayer Ag PARENTERAL FORMULATION OF NIMODIPIN, A METHOD FOR THE PRODUCTION THEREOF AND THEIR USE IN THE FIGHT AGAINST DISEASES
DE3339236A1 (en) * 1983-10-28 1985-05-09 Bayer Ag PREPARATION OF MEDICINAL PRODUCTS
DE4342196A1 (en) * 1993-12-10 1995-06-14 Bayer Ag New 4-phenyl-substituted 1,4-dihydropyridines
FR2568773B1 (en) * 1984-08-10 1989-03-03 Sandoz Lab NEW NASAL ADMINISTRATIVE PHARMACEUTICAL COMPOSITIONS
EP0175671A1 (en) * 1984-08-23 1986-03-26 Kuhlemann & Co. Pharmaceutical preparation and method for the administration of this pharmaceutical preparation
DE3438830A1 (en) * 1984-10-23 1986-04-30 Rentschler Arzneimittel PHARMACEUTICAL FORM CONTAINING NIFEDIPIN AND METHOD FOR THE PRODUCTION THEREOF
DE3544692A1 (en) * 1985-12-18 1987-06-19 Bayer Ag DIHYDROPYRIDINE SPRAY, METHOD FOR THE PRODUCTION THEREOF AND ITS PHARMACEUTICAL USE
US4758669A (en) * 1986-05-05 1988-07-19 Radiation Oncology Center Research And Development Corporation 4-(nitrone aryl) dihydropyridines
US5401759A (en) * 1989-11-16 1995-03-28 Miles Inc. Nimodipine enhanced growth and vascularization of neural grafts
RU1804845C (en) * 1991-02-15 1993-03-30 Институт Органического Синтеза Латвийской Ан Nootropic substance
JP2793410B2 (en) * 1991-04-22 1998-09-03 インターナショナル・ビジネス・マシーンズ・コーポレイション Web drive and tape drive
US5438144A (en) * 1991-07-30 1995-08-01 Troponwerke Gmbh & Co. Kg Use of 1,4-dihydropyridines in diabetes
DE4130173A1 (en) * 1991-09-11 1993-03-18 Bayer Ag PHARMACEUTICAL PREPARATIONS WITH A SPECIAL CRYSTAL MODIFICATION OF 1,4-DIHYDRO-2,6-DIMETHYL-4- (3-NITROPHENYL) -3,5-PYRIDINDICARBONIC ACID ISOPROPYL- (2-METHOXYETHYL) ESTER
DE4133257A1 (en) * 1991-10-08 1993-04-15 Bayer Ag N-METHYL-NIMODIPINE, METHOD FOR THE PRODUCTION THEREOF AND ITS USE AS A CEREBRAL THERAPEUTIC
IT1255792B (en) * 1992-08-05 1995-11-16 Bayer Italia Spa PHARMACEUTICAL COMPOSITIONS FOR THE ORAL ADMINISTRATION OF DIHYDROPYRIDINS IN THE FORM OF DRINK
US6001857A (en) * 1992-10-30 1999-12-14 Bayer Aktiengesellschaft Heterocyclyl substituted dihydropyridines
ATE146788T1 (en) * 1992-10-30 1997-01-15 Bayer Ag 4-HETEROCYCLOPHENYL SUBSTITUTED DIHYDROPYRIDINES
DE4236707A1 (en) * 1992-10-30 1994-05-05 Bayer Ag 4-heterocyclyl substituted dihydropyridines
SE9203857D0 (en) * 1992-12-22 1992-12-22 Astra Ab USE OF AN ENANTIOMERIC DIHYDROPYRIDINE
DE4342193A1 (en) * 1993-12-10 1995-06-14 Bayer Ag Aryl substituted alkoxycarbonyl-1,4-dihydropyridine-5-carboxylic acid esters
EE03192B1 (en) * 1993-12-10 1999-06-15 Bayer Aktiengesellschaft Isopropyl (2-methoxyethyl) -4- (2-chloro-3-cyanophenyl) -1,4-dihydro-2,6-dimethylpyridine-3,5-dicarboxylate, its enantiomers and intermediate, methods for their preparation and use
DK0657432T3 (en) 1993-12-10 2003-07-07 Bayer Ag Phenyl-substituted 1,4-dihydropyridines with cerebral activity
DE4430094A1 (en) 1994-08-25 1996-02-29 Bayer Ag Use of 3,5-dicarboxylic acid ester-1,4-dihydropyridines as a drug
US6078481A (en) * 1998-06-08 2000-06-20 Imation Corp. Tape storage cartridge having two-level tape path
WO2003079972A2 (en) 2002-02-22 2003-10-02 New River Parmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
AR027152A1 (en) * 2000-12-29 2003-03-12 Osmotica Argentina S A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF COGNITIVE CEREBROVASCULAR DISEASE.
DE10142417A1 (en) * 2001-08-31 2003-03-20 Molecular And Clinical Drug Re drug
WO2007047406A2 (en) * 2005-10-14 2007-04-26 Transform Pharmaceuticals, Inc. Liquid pharmaceutical compositions of nimodipine
WO2009032286A2 (en) 2007-09-06 2009-03-12 Nektar Therapeutics Al, Corporation Oligomer-calcium channel blocker conjugates
US9737478B2 (en) * 2009-09-28 2017-08-22 National Institutes of Health (NIH), U.S. Dept. of Health and Human Services (DHHS), The United States of America NIH Division of Extramural Inventions and Technology Resources (DEITR) Treatment of malaria

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2117571C3 (en) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Asymmetrical 1,4-dihydropyridine-33-dicarboxylic acid esters, process for their preparation and their use as pharmaceuticals
DE2117573C3 (en) * 1971-04-10 1978-07-27 Bayer Ag, 5090 Leverkusen Process for the preparation of asymmetrical 1,4-dihydropyridine-3,5dicarboxylic acid esters, and their use as medicaments
GB1430961A (en) * 1972-01-22 1976-04-07 Yamanouchi Pharma Co Ltd 1-substituted-1,4-dihyddrypyridine derivatives
GB1455502A (en) * 1973-02-20 1976-11-10 Yamanouchi Pharma Co Ltd 1,4-dihydropyridine derivatives

Also Published As

Publication number Publication date
EP0004650B1 (en) 1986-01-29
FR2422402B1 (en) 1982-07-02
SG18688G (en) 1989-07-07
EP0004650A1 (en) 1979-10-17
GB2018134A (en) 1979-10-17
DK150479A (en) 1979-10-12
NL930034I2 (en) 1993-10-01
IE51651B1 (en) 1987-02-04
DE2815578A1 (en) 1979-10-18
CH649921A5 (en) 1985-06-28
DE2967573D1 (en) 1986-03-13
AT383271B (en) 1987-06-10
AU4583579A (en) 1979-10-18
FI791162A (en) 1979-10-12
JPS5730089B2 (en) 1982-06-26
BE875457A (en) 1979-10-10
CH649468A5 (en) 1985-05-31
SE447248B (en) 1986-11-03
IT1062201B (en) 1983-07-29
ZA791728B (en) 1980-05-28
NZ190133A (en) 1985-02-28
NO791009L (en) 1979-10-12
ES479474A1 (en) 1979-12-16
PH15574A (en) 1983-02-17
CA1140853A (en) 1983-02-08
ATA262179A (en) 1986-11-15
JPS591412A (en) 1984-01-06
IL57030A0 (en) 1979-07-25
JPS58219117A (en) 1983-12-20
NL7902778A (en) 1979-10-15
LU88273I2 (en) 1994-02-03
IT7921692A0 (en) 1979-04-09
GR71463B (en) 1983-05-30
AU532623B2 (en) 1983-10-06
IE790756L (en) 1979-10-11
US4406906A (en) 1983-09-27
JPS54135776A (en) 1979-10-22
CH640734A5 (en) 1984-01-31
LU81133A1 (en) 1979-11-07
SE7903186L (en) 1979-10-12
NL930034I1 (en) 1993-08-02
HK59188A (en) 1988-08-12
DE2815578C2 (en) 1986-01-16
IL57030A (en) 1982-09-30

Similar Documents

Publication Publication Date Title
FR2422402A1 (en) COMPOSITION BASED ON 3-B-METHOXYETHYL AND 5-ISOPROPYL ESTER OF 1,4-DIHYDRO-2,6-DIMETHYL-4- (3'-NITROPHENYL) PYRIDINE, INTENDED FOR CEREBRAL THERAPEUTICS
GR1001503B (en) Method for the preparation of pharmaceutical compounds containing carbonic acids containing sulphur and the use thereof in fighting retroviruses.
BE864726A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING CHOLESTYRAMINE
ES480350A1 (en) Nitro 1,4-dihydropyridines, medicaments containing them and their manufacture.
ES485540A1 (en) 1,4-Dihydropyridine compounds, their preparation, pharmaceutical compositions containing said compounds and preparation of these compositions.
KR910700040A (en) Tooth whitening agent
IT8753157V0 (en) DENTAL SYRINGE FOR INTRALEGAMENTARY INJECTIONS
FR2374910A1 (en) PREPARATION BASED ON HEPARIN, INCLUDING LIPOSOMES, PROCESS FOR OBTAINING IT AND MEDICINAL PRODUCTS CONTAINING SUCH PREPARATIONS
NL182049C (en) TOOTHMASS FOR TOOTH FILLINGS AND TOOTH REPLACEMENT PARTS.
FI822414L (en) SYROR AV N-SUBSTITUERADE 2-PYRROLIDON-4-CARBOXYLSYROR SOM BEFUKTNINGSMEDEL
IT8620902A0 (en) COMPOSITIONS CONTAINING USNIC ACID OR ITS DERIVATIVES SUITABLE FOR USE IN THE TREATMENT OF DENTAL CARIES.
OA06797A (en) Platinum compound, method of preparation and pharmaceutical compositions containing it.
NL960024I2 (en) Pharmaceutical composition comprising 3'-deoxythymidine-2'-ene (3'-deoxy-2 ', 3'-didehydrothymidine) for the treatment of patients infected with retrovirus.
DE3889302D1 (en) 9- (Acylamino) tetrahydroacridine derivatives and perceptual agents thereof as an active ingredient.
FR2600253B1 (en) NEW PHARMACEUTICAL COMPOSITIONS BASED ON KETOTIFENE
DE3877063D1 (en) PHOTOPOLYMERIZABLE DENTAL COMPOSITION.
IT8521322A0 (en) PHARMACEUTICAL COMPOUNDS AND COMPOSITIONS FOR THE THERAPY OF RETINOPATHIES AND DIABETIC NEUROPATHIES.
MC1878A1 (en) PHARMACEUTICAL COMPOSITIONS
PT1150703E (en) MULTIPLE SCLEROSIS THERAPY WITH CHAPERONINE 10 AND BETA-INTERFERENCE
KR850008664A (en) Method for preparing (S)-and (R) -enantiomers of 4-amino-N- (1-phenylethyl) benzamide
ATA239688A (en) DENTAL SYRINGE HANDPIECE
OA06373A (en) New pharmaceutical compositions based on aryltrifluoroetanols.
BR7601824A (en) DENTAL ALLOY AND DENTAL AMALGAM
FR2609392B1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING PYRANOQUINOLEINS
DE68901491D1 (en) METHOD TO PREVENT THE DISCOLORATION OF EMULSIONS AND EMULSION COMPOSITION RESISTANT TO DISCOLORATION.

Legal Events

Date Code Title Description
ST Notification of lapse